Understanding the Prevalence and Mortality of Acute Right Ventricular Strain in Covid-19 Patients, an Observational Analysis

Authors

  • Pejmahn Eftekharzadeh Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA Author
  • Muneeba Azmat Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA Author
  • Elena Sokolova Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA Author
  • Bereket Tewoldemedhin Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA Author
  • Andrea Davila Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA Author
  • Shahzad Ahmed Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA Author

DOI:

https://doi.org/10.47363/JCRRR/2022(3)161

Keywords:

COVID-19, Ventricular Dysfunction, Heart Strain, Pulmonary Embolism, Echocardiography, SARS-COV-2.

Abstract

Coronavirus disease 2019 or COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), a virus that has impacted nations 
and caused a global pandemic. Although COVID-19 is known to initially manifest as a pulmonary disease, we now understand it affects many major organ systems in the body, including the heart. Case reports have been published showing evidence of right ventricular (RV) strain as a result of contracting the COVID-19. However, the overall prevalence of RV strain secondary to the virus has not been well established. In this multicenter, observational analysis, we studied the prevalence of RV strain in hospitalized patients with COVID-19. We found the prevalence of RV strain to be small, ~1.5%. The average length of stay in patients with RV strain was 7 days compared to 8.63 days in non-RV strain patients. Those with RV strain were witness to have a 50% mortality rate.

Author Biographies

  • Pejmahn Eftekharzadeh, Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

    Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

  • Muneeba Azmat, Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

    Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

  • Elena Sokolova, Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

    Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

  • Bereket Tewoldemedhin, Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

    Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

  • Andrea Davila, Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

    Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

  • Shahzad Ahmed, Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

    Lower Bucks Hospital – Internal Medicine, Lower Bucks Hospital 501, Bath Road Bristol, PA 19007, USA

Downloads

Published

2022-03-17

Issue

Vol. 3 No. 2 (2022): volume 3 Issue 2

Section

Articles